Home > Drug Search >
  • company_query: Aderis Pharmaceuticals
  •   > 
Drug Filter
Category:
chemistry (27) biology (1)
Status:
NDA Filing (2) Phase Ⅲ (7) Phase Ⅱ (12) Phase Ⅰ (6) IND Filing (1)
Clinical Stage:
Pending (4) Active (10) Discontinued (14)
Indication:
Allergic rhinitis (AR) (1) Alzheimer's disease (AD) (1) Amyotrophic lateral sclerosis (ALS) (2) Anxiety (1) Asthma (1) Atopic dermatitis (1) Breast cancer (1) Candidiasis (1) Rectal cancer (1) Chronic obstructive pulmonary disease (COPD) (1) Crohn's disease (1) Cystic fibrosis (CF) (2) Dry eye disease (1) Endometriosis (1) Gastric cancer (1) Germline BRCA mutated advanced ovarian cancer (1) Heart failure (2) Lung cancer (1) Malignancies (1) Non small cell lung cancer (NSCLC) (1) Non-Hodgkin B-cell lymphomas (1) Osteoarthritis (OA) (1) Ovarian cancer (1) Parkinson's disease (PD) (1) Partial seizures (1) Psoriasis (2) Sjoegren's syndrome (1) Solid tumours (3) Tinnitus (1) Primary peritoneal cancer (1) Fallopian tube cancer (1) Epithelial ovarian cancer (1) Septic shock (1) Gram-positive bacterial infection (1) Fractures (1) Immunodeficiency disorders (1) Cardiovascular disorders (2) Meniere's disease (1) Organ failure (1)
Others:
Sort: Aprv. Year Alphabetical Prev Next
First Prev 1 2 Next Last GO
Recently Viewed Drugs:
Insert title here
Feed-Back To Top
ICP Permit 14047345| Beijing PSB Hai Dian Record 11010802017043 |(京)-经营性-2015-0023(互联网药品信息服务资格证书)
Insert title here
Feed-Back To Top